Pemphigus is a rare group of autoimmune skin conditions that cause painful blisters and sores to form on the skin and inside the mouth, affecting daily life in profound ways and requiring lifelong medical management to control symptoms and prevent serious complications.

Understanding the Scope: How Common Is Pemphigus?

Pemphigus is an uncommon condition that affects a very small portion of the global population. Each year, approximately 1 to 5 out of every 1 million people worldwide receive a diagnosis of pemphigus^[1]. This rarity means that many people have never heard of the condition, and even some healthcare providers may encounter it only a few times in their careers. Despite its infrequent occurrence, pemphigus has a significant impact on those who develop it, requiring specialized care and long-term treatment strategies.

The condition does not affect all populations equally. Certain geographical regions and ethnic groups show higher rates of pemphigus cases. Southeast Europe, India, the Middle East, Tunisia, and Brazil report more cases compared to other parts of the world^[1]. Additionally, people of Jewish and Indian descent appear to be at higher risk than other populations, likely due to genetic factors that predispose them to developing this autoimmune condition^[5].

Pemphigus typically develops in middle-aged and older adults, with most cases appearing between the ages of 40 and 60 years^[1][3]. The condition can occur at any age, but the onset in younger adults or children is less common. Both men and women are affected equally by pemphigus, with no clear gender preference in most types of the disease^[3]. The age-related pattern suggests that certain immune system changes that accumulate over decades may contribute to the development of this condition.

What Causes Pemphigus to Develop?

Pemphigus is fundamentally an autoimmune disorder, which means that the body’s immune system mistakenly attacks its own healthy tissues. In a properly functioning immune system, special proteins called antibodies are produced to recognize and destroy harmful invaders like bacteria and viruses. However, in pemphigus, something goes wrong with this protective mechanism. Instead of targeting germs, the immune system creates antibodies that attack the skin and mucous membranes by mistake^[2].

The specific target of these misguided antibodies in pemphigus are proteins called desmogleins, particularly desmoglein 3 (DSG3) and desmoglein 1 (DSG1)^[5]. These proteins are critical components of structures called desmosomes, which act like glue to hold skin cells together. When antibodies bind to desmogleins, they interfere with the normal function of desmosomes, causing skin cells to separate from each other in a process called acantholysis^[3]. This separation creates spaces between cells that fill with fluid, forming the characteristic blisters seen in pemphigus.

While researchers understand the mechanism of how blisters form, the underlying reason why the immune system begins producing these harmful antibodies remains largely unknown. Scientists believe that genetic factors play a role, as certain variations in genes related to immune function, particularly the human leukocyte antigen (HLA) system, are more common in people with pemphigus. Specific HLA alleles, such as HLA-DRB1 0402 in Ashkenazi Jews and DRB1 1401/04 and DQB1 0503 in people of European or Asian descent, have been linked to increased susceptibility^[3].

Environmental factors may also play a triggering role in people who are genetically predisposed to pemphigus. Various triggers have been reported, though the exact relationship between these factors and disease onset is not always clear. Certain medications can induce pemphigus in some individuals, particularly drugs containing thiol or phenol compounds. These include penicillamine, angiotensin-converting enzyme inhibitors (used for blood pressure), angiotensin receptor blockers, and cephalosporin antibiotics^[5][8]. When medication is the cause, blisters may develop months after starting the drug, and stopping the medication may lead to improvement in symptoms.

Other potential triggers that have been documented include viral infections, with some epidemiological studies suggesting a rare link between herpes virus infection and pemphigus^[5]. Additional factors such as diet, stress, ultraviolet radiation, ionizing radiation therapy, pesticides, allergens, and even some vaccines have been reported in the medical literature as possible triggers, though these connections require further study^[8]. It is important to understand that pemphigus is not contagious and cannot be spread from person to person through contact^[1][2].

Risk Factors: Who Is More Likely to Develop Pemphigus?

Several factors can increase the likelihood of developing pemphigus, though having these risk factors does not guarantee that someone will develop the condition. Age is a significant consideration, as pemphigus most commonly appears in people between 40 and 60 years old^[1]. While the condition can occur at any age, middle-aged and older adults face a higher risk than younger individuals. This age-related pattern may reflect the cumulative effect of various environmental exposures and age-related changes in immune system function.

Ethnicity and geographic origin play important roles in pemphigus risk. People of Jewish, Indian, southeast European, and Middle Eastern ancestry have higher rates of the disease compared to other ethnic groups^[1][5]. This increased risk in certain populations is believed to stem from genetic variations that are more common in these groups. Individuals living in or originating from specific regions including Southeast Europe, India, the Middle East, Tunisia, and Brazil also face elevated risk.

Certain medications can trigger pemphigus in susceptible individuals. Drugs containing thiol groups, such as penicillamine (used for conditions like rheumatoid arthritis and Wilson’s disease), are well-known triggers. Blood pressure medications, particularly angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, have also been associated with drug-induced pemphigus. Antibiotics in the cephalosporin family may trigger the condition as well^[5]. For people taking these medications, blisters may appear months after starting treatment, and the condition may improve if the medication is discontinued.

Having other autoimmune disorders may increase the risk of developing pemphigus, as people with one autoimmune condition sometimes develop additional autoimmune diseases. In rare cases, cancer can trigger a specific type called paraneoplastic pemphigus, which occurs in people diagnosed with certain cancers, particularly lymphomas and Castleman disease^[1][5]. Physical trauma to the skin or mucous membranes has also been reported as a potential trigger in some cases.

Recognizing the Symptoms of Pemphigus

The hallmark symptom of pemphigus is the formation of blisters on the skin and mucous membranes. These blisters have distinctive characteristics that distinguish them from other skin conditions. They are typically thin-walled and fragile, breaking open easily to leave very sore, raw areas that are susceptible to infection^[1][2]. The fragility of these blisters is so pronounced that in some cases, large areas of skin can peel off with just a light rub of the finger.

In the most common type, pemphigus vulgaris, symptoms almost always begin inside the mouth. Painful blisters and sores develop on the mucous membranes lining the mouth and throat, which can make swallowing, talking, drinking, and eating extremely difficult^[1][2]. These oral lesions may appear as water-filled blisters that break easily when touched by the tongue, leaving behind painful erosions. The mouth may feel slimy, and the sores heal very slowly. Many people with pemphigus vulgaris first notice these oral symptoms weeks or even months before skin blisters appear.

When skin blisters do develop, they commonly appear on the upper chest, back, scalp, face, and areas near the groin^[5]. The blisters are filled with clear fluid and can vary in size. After they break, they leave behind painful, raw patches that can cover large areas of the body. These open sores are not only painful but also pose a significant risk for bacterial infection, which can lead to serious complications if not properly managed.

In pemphigus foliaceus, a different type of pemphigus, the blisters typically affect the outermost layer of skin only and rarely appear in the mouth. Instead, small blisters develop on the scalp, face, neck, back, and upper chest. These blisters break very easily to form crusty, scaly lesions that can spread to cover extensive areas of skin^[1]. The lesions in pemphigus foliaceus may be itchy or painful but are generally less severe than those in pemphigus vulgaris.

Other areas that can be affected by pemphigus blisters include the eyes, genitals, anus, nose, throat, and larynx (voice box)^[2][5]. When the eyes are involved, the conjunctiva (the membrane covering the white part of the eye) may be affected. Genital involvement can cause pain during sexual activity and when urinating. Nasal lesions can lead to congestion and nosebleeds. If the throat and larynx are affected, people may experience a hoarse voice and severe pain when swallowing.

In people with darker skin tones, the presentation of pemphigus may differ slightly, which can sometimes lead to delays in diagnosis. Instead of the typical appearance, blisters may lack the surrounding redness (erythema) commonly seen in lighter skin. Affected areas may show hyperpigmented (darkened) plaques with superficial erosions and hemorrhagic (bloody) crusting. At later stages, the lesions may appear as plaques with a pink base surrounded by areas of hyperpigmentation^[5].

Preventing Pemphigus and Managing Risk

Because the exact cause of pemphigus remains unknown, there are no definitive strategies for preventing the condition from developing in the first place. However, for people who have already been diagnosed with pemphigus, understanding potential triggers can help manage the disease and possibly reduce the frequency or severity of flare-ups.

For individuals with known risk factors, such as those of Jewish, Indian, or Middle Eastern ancestry, or those living in high-prevalence regions, awareness of early symptoms is important. Recognizing blisters or persistent sores in the mouth early and seeking medical evaluation promptly can lead to earlier diagnosis and treatment, which may prevent the condition from worsening.

People taking medications known to potentially trigger pemphigus should be aware of this risk. If blisters or mouth sores develop while taking medications such as penicillamine, ACE inhibitors, or certain antibiotics, it is essential to inform a healthcare provider immediately. In cases of drug-induced pemphigus, stopping the offending medication (under medical supervision) may lead to improvement and resolution of symptoms^[7]. However, patients should never stop prescribed medications without first consulting their healthcare provider.

Managing stress may be beneficial for people with pemphigus or those at risk, as stress has been reported as a potential trigger or exacerbating factor for autoimmune conditions^[8]. While completely avoiding stress is unrealistic, learning stress management techniques such as meditation, deep breathing exercises, or engaging in enjoyable hobbies may help maintain better overall health and potentially reduce the risk of disease flares.

Regular medical check-ups are important, especially for people with other autoimmune conditions or those taking high-risk medications. Healthcare providers can monitor for early signs of pemphigus and provide prompt intervention if symptoms develop. For people already diagnosed with pemphigus, following the prescribed treatment plan carefully and attending all scheduled follow-up appointments is essential for preventing relapses and managing the condition effectively.

How Pemphigus Changes the Body: Understanding Pathophysiology

To understand how pemphigus affects the body, it helps to know how healthy skin is normally structured. The outer layer of skin, called the epidermis, is made up of cells called keratinocytes. These cells are held tightly together by specialized structures called desmosomes, which function like rivets or spot welds to keep the skin intact and provide a protective barrier against the outside environment.

Desmosomes contain several proteins, including desmogleins, which are critical for maintaining the connection between skin cells. In pemphigus, the immune system produces immunoglobulin G (IgG) autoantibodies that specifically target desmoglein proteins^[3][5]. When these antibodies bind to desmogleins, they disrupt the normal function of desmosomes, causing the connections between keratinocytes to break down.

This breakdown process is called acantholysis, which literally means the loosening or separation of cells^[3]. As the connections between keratinocytes are destroyed, the cells separate from each other, creating spaces that fill with fluid. This fluid accumulation forms the characteristic blisters seen in pemphigus. Because the cell-to-cell connections are so disrupted, the blisters are fragile and break easily, leaving behind raw, painful erosions.

In pemphigus vulgaris, the most common type, autoantibodies target primarily desmoglein 3 (DSG3), which is found in the deeper layers of the epidermis and in mucous membranes. This is why pemphigus vulgaris always affects the mouth and often involves other mucous membranes^[5]. About half of people with pemphigus vulgaris also have antibodies against desmoglein 1 (DSG1), which is found in the upper layers of the epidermis. When both DSG3 and DSG1 antibodies are present, both skin and mucous membranes are affected.

In pemphigus foliaceus, the autoantibodies target only desmoglein 1, which is concentrated in the outermost layers of the skin. This explains why pemphigus foliaceus causes blisters in the superficial skin layers and rarely affects mucous membranes like the mouth. The blisters in this type are even more fragile because they form at the very surface of the skin, leading to the crusty, scaly appearance characteristic of this condition.

The level in the epidermis where acantholysis occurs determines the clinical appearance and behavior of the blisters. In pemphigus vulgaris, blistering occurs in the deeper layers of the epidermis (suprabasal layer), creating blisters with a thin roof that breaks easily. In pemphigus foliaceus, the split occurs just below the outermost layer (subcorneal), resulting in very superficial blisters that rupture almost immediately to form crusts and scales.

Beyond the direct effects on skin structure, pemphigus affects multiple body systems. When extensive areas of skin are damaged, the body loses its protective barrier, increasing vulnerability to bacterial, fungal, and viral infections. Large open sores can lead to significant fluid loss, similar to burn injuries, which can affect electrolyte balance and overall hydration. When the mouth and throat are severely affected, eating and drinking become painful and difficult, potentially leading to malnutrition and weight loss^[2].